Kezar Life Sciences, Inc. 8-K SEC Filings

Filed On	Filing
11 May 2026	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
03 Apr 2026	8-K: Termination of a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
30 Mar 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
12 Mar 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
12 Nov 2025	8-K: Results of Operations and Financial Condition
07 Nov 2025	8-K: Costs Associated with Exit or Disposal Activities
22 Oct 2025	8-K: Termination of a Material Definitive Agreement
16 Oct 2025	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more
13 Aug 2025	8-K: Results of Operations and Financial Condition
23 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
13 May 2025	8-K: Results of Operations and Financial Condition
01 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
25 Mar 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
27 Feb 2025	8-K: Other Events
10 Jan 2025	8-K: Results of Operations and Financial Condition
03 Dec 2024	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders
14 Nov 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
12 Nov 2024	8-K: Results of Operations and Financial Condition
28 Oct 2024	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
17 Oct 2024	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +3 more

Comments